cristovao / Shutterstock.com
The English High Court has said it will not send a patent infringement case filed by Pfizer-owned Warner-Lambert Company against Actavis to trial, finding there was no “serious issue”.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Pfizer, Warner-Lambert Company, Actavis, patent, English High Court, generic drugs